Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05506176 |
| Consolidated Lead Sponsor | Jiangsu Simcere Pharmaceutical Co |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 1,208 participants (ACTUAL) |
| Registered Start Date | 2022-08-19 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.